T Cell Dysfunction by Hepatitis C Virus Core Protein Involves PD-1/PDL-1 Signaling
Overview
Microbiology
Affiliations
Reports have shown that a negative T cell costimulatory pathway mediated by PD-1 (programmed death-1) and PDL-1 (programmed death ligand-1) is associated with T cell exhaustion and persistent viral infection. Persistent hepatitis C virus (HCV) infection in humans is also characterized by impaired T lymphocyte function, but the role of the PD-1 and PDL-1 pathway in HCV infection is unknown. Here we report that T cells isolated from chronically HCV-infected patients express significantly higher levels of PD-1 when compared with healthy donors. In addition, PD-1 and PDL-1 expression is upregulated on healthy donor T cells exposed to HCV core, a nucleocapsid protein that is immunosuppressive; upregulation of PD-1 is mediated through interaction of HCV core with the complement receptor, gC1qR. Importantly, T cell functions that are dysregulated by HCV core, including T cell activation, proliferation, and apoptosis, can be restored by blocking PD-1 and PDL-1 engagement. Our results indicate that HCV core can upregulate a key negative T cell signaling pathway associated with viral persistence and highly expressed on the T cells of persistently infected individuals. This upregulation of the PD-1 and PDL-1 pathway in humans represents a novel and perhaps common mechanism by which a virus usurps host machinery to facilitate persistence.
Emerging Role of PD-1/PD-L1 Inhibitors in Chronic Liver Diseases.
Singh V, Khurana A, Allawadhi P, Banothu A, Bharani K, Weiskirchen R Front Pharmacol. 2022; 12:790963.
PMID: 35002724 PMC: 8733625. DOI: 10.3389/fphar.2021.790963.
Wroblewska A, Bielawski K, Sikorska K J Clin Med. 2021; 10(24).
PMID: 34945170 PMC: 8707082. DOI: 10.3390/jcm10245874.
Liu Y, Wu C, Chen N, Li Y, Fan C, Zhao S Front Immunol. 2021; 12:727254.
PMID: 34552590 PMC: 8450576. DOI: 10.3389/fimmu.2021.727254.
Hepatocellular Carcinoma-The Influence of Immunoanatomy and the Role of Immunotherapy.
Patel K, Lamm R, Altshuler P, Dang H, Shah A Int J Mol Sci. 2020; 21(18).
PMID: 32942580 PMC: 7555667. DOI: 10.3390/ijms21186757.
Bekerman E, Hesselgesser J, Carr B, Nagel M, Hung M, Wang A Antimicrob Agents Chemother. 2019; 63(11).
PMID: 31501143 PMC: 6811450. DOI: 10.1128/AAC.01163-19.